Rhinocort Allergy

Proteinuria, Asthma, Itching + 16 more

Treatment

20 Active Studies for Rhinocort Allergy

What is Rhinocort Allergy

Budesonide

The Generic name of this drug

Treatment Summary

Budesonide is a steroid medication used to treat inflammation of the lungs and intestines. It is prescribed for conditions such as asthma, COPD, Crohn's disease, and ulcerative colitis. Budesonide was approved by the FDA in 1994 and is sold under the brand name Pulmicort.

Rhinocort

is the brand name

image of different drug pills on a surface

Rhinocort Allergy Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Rhinocort

Budesonide

1994

134

Effectiveness

How Rhinocort Allergy Affects Patients

Budesonide is a medication used to treat respiratory and digestive issues caused by inflammation. The dose varies from person to person, but it is generally considered to be a safe drug. However, people should be aware of the potential side effects, like hypercorticism and suppression of the adrenal axis.

How Rhinocort Allergy works in the body

Corticosteroids work to reduce inflammation by decreasing the activity of certain proteins. These proteins can cause swelling or stop white blood cells from getting to the site of inflammation. Low doses of corticosteroids reduce inflammation, while higher doses can weaken the immune system. They also affect sodium and potassium levels in the body, leading to further changes in the body.

When to interrupt dosage

The endorsed dosage of Rhinocort Allergy relies upon the diagnosed condition, for instance Vasomotor Rhinitis, Crohn's Disease, and Chronic Obstructive Pulmonary Disease (COPD). The amount of dosage shifts, depending on the technique of delivery (e.g. Enema; Kit; Tablet - Rectal or Respiratory (inhalation)) as indicated in the table below.

Condition

Dosage

Administration

Itching

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Enema; Kit; Tablet, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Capsule, delayed release - Oral, Patch - Cutaneous, Patch, Tablet, orally disintegrating - Oral, Kit, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release, Capsule, delayed release pellets - Oral, Capsule, delayed release pellets, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, orally disintegrating, Cutaneous, Kit - Rectal

Colitis, Collagenous

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Enema; Kit; Tablet, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Capsule, delayed release - Oral, Patch - Cutaneous, Patch, Tablet, orally disintegrating - Oral, Kit, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release, Capsule, delayed release pellets - Oral, Capsule, delayed release pellets, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, orally disintegrating, Cutaneous, Kit - Rectal

Rhinitis, Vasomotor

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Enema; Kit; Tablet, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Capsule, delayed release - Oral, Patch - Cutaneous, Patch, Tablet, orally disintegrating - Oral, Kit, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release, Capsule, delayed release pellets - Oral, Capsule, delayed release pellets, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, orally disintegrating, Cutaneous, Kit - Rectal

Crohn's Disease

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Enema; Kit; Tablet, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Capsule, delayed release - Oral, Patch - Cutaneous, Patch, Tablet, orally disintegrating - Oral, Kit, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release, Capsule, delayed release pellets - Oral, Capsule, delayed release pellets, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, orally disintegrating, Cutaneous, Kit - Rectal

Eosinophilic Esophagitis

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Enema; Kit; Tablet, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Capsule, delayed release - Oral, Patch - Cutaneous, Patch, Tablet, orally disintegrating - Oral, Kit, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release, Capsule, delayed release pellets - Oral, Capsule, delayed release pellets, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, orally disintegrating, Cutaneous, Kit - Rectal

Hypersensitivity

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Enema; Kit; Tablet, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Capsule, delayed release - Oral, Patch - Cutaneous, Patch, Tablet, orally disintegrating - Oral, Kit, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release, Capsule, delayed release pellets - Oral, Capsule, delayed release pellets, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, orally disintegrating, Cutaneous, Kit - Rectal

Crohn Disease

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Enema; Kit; Tablet, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Capsule, delayed release - Oral, Patch - Cutaneous, Patch, Tablet, orally disintegrating - Oral, Kit, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release, Capsule, delayed release pellets - Oral, Capsule, delayed release pellets, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, orally disintegrating, Cutaneous, Kit - Rectal

Acute Coryza

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Enema; Kit; Tablet, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Capsule, delayed release - Oral, Patch - Cutaneous, Patch, Tablet, orally disintegrating - Oral, Kit, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release, Capsule, delayed release pellets - Oral, Capsule, delayed release pellets, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, orally disintegrating, Cutaneous, Kit - Rectal

Nasal Polyps

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Enema; Kit; Tablet, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Capsule, delayed release - Oral, Patch - Cutaneous, Patch, Tablet, orally disintegrating - Oral, Kit, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release, Capsule, delayed release pellets - Oral, Capsule, delayed release pellets, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, orally disintegrating, Cutaneous, Kit - Rectal

Nasal Congestion

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Enema; Kit; Tablet, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Capsule, delayed release - Oral, Patch - Cutaneous, Patch, Tablet, orally disintegrating - Oral, Kit, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release, Capsule, delayed release pellets - Oral, Capsule, delayed release pellets, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, orally disintegrating, Cutaneous, Kit - Rectal

IGA Glomerulonephritis

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Enema; Kit; Tablet, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Capsule, delayed release - Oral, Patch - Cutaneous, Patch, Tablet, orally disintegrating - Oral, Kit, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release, Capsule, delayed release pellets - Oral, Capsule, delayed release pellets, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, orally disintegrating, Cutaneous, Kit - Rectal

Sinusitis

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Enema; Kit; Tablet, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Capsule, delayed release - Oral, Patch - Cutaneous, Patch, Tablet, orally disintegrating - Oral, Kit, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release, Capsule, delayed release pellets - Oral, Capsule, delayed release pellets, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, orally disintegrating, Cutaneous, Kit - Rectal

Crohn Disease

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Enema; Kit; Tablet, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Capsule, delayed release - Oral, Patch - Cutaneous, Patch, Tablet, orally disintegrating - Oral, Kit, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release, Capsule, delayed release pellets - Oral, Capsule, delayed release pellets, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, orally disintegrating, Cutaneous, Kit - Rectal

Proteinuria

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Enema; Kit; Tablet, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Capsule, delayed release - Oral, Patch - Cutaneous, Patch, Tablet, orally disintegrating - Oral, Kit, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release, Capsule, delayed release pellets - Oral, Capsule, delayed release pellets, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, orally disintegrating, Cutaneous, Kit - Rectal

Asthma

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Enema; Kit; Tablet, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Capsule, delayed release - Oral, Patch - Cutaneous, Patch, Tablet, orally disintegrating - Oral, Kit, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release, Capsule, delayed release pellets - Oral, Capsule, delayed release pellets, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, orally disintegrating, Cutaneous, Kit - Rectal

Skin Diseases

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Enema; Kit; Tablet, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Capsule, delayed release - Oral, Patch - Cutaneous, Patch, Tablet, orally disintegrating - Oral, Kit, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release, Capsule, delayed release pellets - Oral, Capsule, delayed release pellets, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, orally disintegrating, Cutaneous, Kit - Rectal

Chronic Obstructive Pulmonary Disease

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Enema; Kit; Tablet, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Capsule, delayed release - Oral, Patch - Cutaneous, Patch, Tablet, orally disintegrating - Oral, Kit, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release, Capsule, delayed release pellets - Oral, Capsule, delayed release pellets, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, orally disintegrating, Cutaneous, Kit - Rectal

Ulcerative Colitis

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Enema; Kit; Tablet, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Capsule, delayed release - Oral, Patch - Cutaneous, Patch, Tablet, orally disintegrating - Oral, Kit, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release, Capsule, delayed release pellets - Oral, Capsule, delayed release pellets, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, orally disintegrating, Cutaneous, Kit - Rectal

maintenance therapy

, 0.25 mg/mL, 0.5 mg/mL, 1.0 mg/mL, 0.09 mg, 0.032 mg, 3.0 mg, 0.18 mg, 0.2 mg, 0.5 mg, 9.0 mg, 28.0 mg, 2.3 mg, 0.08 mg, 0.16 mg, 0.00008 mg/hour, 0.32 mg, 1.0 mg, 6.0 mg, 0.125 mg/mL, 4.0 mg, 0.064 mg/pump actuation, 0.4 mg/pump actuation, 0.1 mg/pump actuation, 2.0 mg/pump actuation, 0.2 mg/pump actuation, 0.182 mg/pump actuation

Respiratory (inhalation), Inhalant, , Inhalant - Respiratory (inhalation), Suspension, Suspension - Respiratory (inhalation), Aerosol, powder - Respiratory (inhalation), Aerosol, powder, Nasal, Spray, metered, Capsule, Spray, metered - Nasal, Oral, Capsule - Oral, Powder - Respiratory (inhalation), Powder, Aerosol, metered, Aerosol, metered - Nasal, Tablet, extended release, Tablet, extended release - Oral, Rectal, Aerosol, foam - Rectal, Aerosol, foam, Enema; Kit; Tablet - Rectal, Capsule, extended release, Capsule, extended release - Oral, Enema; Kit; Tablet, Capsule, coated pellets - Oral, Capsule, coated pellets, Nasal; Respiratory (inhalation), Aerosol, Aerosol - Respiratory (inhalation), Powder, metered, Powder, metered - Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Capsule, delayed release - Oral, Patch - Cutaneous, Patch, Tablet, orally disintegrating - Oral, Kit, Powder - Nasal; Respiratory (inhalation), Capsule, delayed release, Capsule, delayed release pellets - Oral, Capsule, delayed release pellets, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Inhalant - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Tablet, orally disintegrating, Cutaneous, Kit - Rectal

Warnings

Rhinocort Allergy has five contraindications and should not be integrated with the ailments outlined in the following table.

Rhinocort Allergy Contraindications

Condition

Risk Level

Notes

Asthma

Do Not Combine

Severe Hepatic Impairment

Do Not Combine

Status Asthmaticus

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Budesonide may interact with Pulse Frequency

Severe Hypersensitivity Reactions

Do Not Combine

Budesonide may interact with Pulse Frequency

There are 20 known major drug interactions with Rhinocort Allergy.

Common Rhinocort Allergy Drug Interactions

Drug Name

Risk Level

Description

2-Methoxyethanol

Major

The risk or severity of adverse effects can be increased when Budesonide is combined with 2-Methoxyethanol.

9-(N-methyl-L-isoleucine)-cyclosporin A

Major

The risk or severity of adverse effects can be increased when Budesonide is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.

Abatacept

Major

The risk or severity of adverse effects can be increased when Budesonide is combined with Abatacept.

Abemaciclib

Major

The metabolism of Abemaciclib can be increased when combined with Budesonide.

Abetimus

Major

The risk or severity of adverse effects can be increased when Budesonide is combined with Abetimus.

Rhinocort Allergy Toxicity & Overdose Risk

Acute overdosing on corticosteroids is uncommon, but taking too much for too long can cause increased levels of cortisol and disrupt the hormone balance. If an overdose occurs, the dose of corticosteroids should be reduced temporarily. A 200mg dose is deadly for female mice, and 400mg for male mice.

image of a doctor in a lab doing drug, clinical research

Rhinocort Allergy Novel Uses: Which Conditions Have a Clinical Trial Featuring Rhinocort Allergy?

516 active clinical trials are currently examining the potential of Rhinocort Allergy to alleviate Chronic Obstructive Pulmonary Disease (COPD), Ulcerative Colitis and Allergic Symptoms.

Condition

Clinical Trials

Trial Phases

Itching

4 Actively Recruiting

Phase 3, Not Applicable, Early Phase 1

Chronic Obstructive Pulmonary Disease

73 Actively Recruiting

Phase 3, Phase 1, Phase 2, Not Applicable, Early Phase 1, Phase 4

Asthma

87 Actively Recruiting

Phase 1, Phase 4, Early Phase 1, Not Applicable, Phase 2, Phase 3

Proteinuria

6 Actively Recruiting

Phase 2, Phase 3, Phase 4, Phase 1, Not Applicable

IGA Glomerulonephritis

0 Actively Recruiting

Ulcerative Colitis

22 Actively Recruiting

Phase 3, Phase 2, Phase 1, Not Applicable, Phase 4

Sinusitis

0 Actively Recruiting

Crohn's Disease

53 Actively Recruiting

Phase 1, Phase 2, Not Applicable, Phase 3, Phase 4, Early Phase 1

Hypersensitivity

1 Actively Recruiting

Phase 4

Colitis, Collagenous

0 Actively Recruiting

Skin Diseases

0 Actively Recruiting

maintenance therapy

0 Actively Recruiting

Rhinitis, Vasomotor

1 Actively Recruiting

Not Applicable

Eosinophilic Esophagitis

0 Actively Recruiting

Acute Coryza

0 Actively Recruiting

Crohn Disease

0 Actively Recruiting

Nasal Polyps

0 Actively Recruiting

Crohn Disease

0 Actively Recruiting

Nasal Congestion

0 Actively Recruiting

Rhinocort Allergy Reviews: What are patients saying about Rhinocort Allergy?

5

Patient Review

6/18/2016

Rhinocort Allergy for Allergic Rhinitis Prevention

So far, so good! I've been using this for a few days now and it's given me the same relief as Nasonex at a lower price point.

3

Patient Review

11/11/2021

Rhinocort Allergy for Allergic Rhinitis Prevention

Budesonide unfortunately has caused my hair to fall out each of the three or four times I've tried it.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about rhinocort allergy

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Rhinocort good for allergies?

"Budesonide is a steroid nasal spray that is a good first-choice option for nasal allergies. It is available as a lower-cost generic form. However, using it regularly for a long time can increase the risk for side effects, such as nosebleeds or fungal infection in the nose."

Answered by AI

Is Rhinocort Allergy discontinued?

"The brand rhinocort is no longer available but the generic prescription budesonide is available. There are no plans to discontinue generic prescription budesonide."

Answered by AI

When should you not use Rhinocort?

"Do not use Rhinocort if you are under 6 years of age or if it has expired as it may be harmful."

Answered by AI

Clinical Trials for Rhinocort Allergy

Image of Cliantha Research in Mississauga, Canada.

Oxymetazoline Nasal Gel for Stuffy Nose

18 - 65
All Sexes
Mississauga, Canada

Nasal congestion (a "stuffy nose") is a common symptom of colds and seasonal or year-round allergies. It happens when the tiny blood vessels and tissues inside the nose swell and leak fluid, producing more mucus. That swelling and extra fluid make the nasal passages narrower, which can make it hard to breathe through the nose, sleep, or do daily activities. Oxymetazoline works on alpha-adrenergic receptors in the tiny blood vessels inside the nose. When these receptors are activated, the blood vessels tighten (constrict), which helps reduce swelling and open the nasal passages. The study drug, oxymetazoline hydrochloride (HCl) 0.05% nasal gel, is a gel form of a well-known decongestant that is typically available as a nasal spray. The gel may remain in contact with the nose longer than a spray and could feel different to use. The main purpose of this study is to learn how well a single dose of oxymetazoline HCl 0.05% nasal gel relieves nasal congestion within the first 2 hours after dosing using two different measures. The study will also look at safety and how well people tolerate the gel.

Phase 2
Recruiting

Cliantha Research

Bayer

Image of Waianae Coast Comprehensive Health Center in Waianae, United States.

Community Program for Youth Well-Being

12 - 25
All Sexes
Waianae, HI

The goal of this pilot clinical trial is to learn if a community referral program can improve services for youth with mental health and chronic health conditions in a predominantly Native Hawaiian and Pacific Islander community. The main questions the trial aims to address are: * What is the best way for a community health center to connect youth with community programs rooted in cultural practices and traditions? * Does participation in community programs engage youth and mental health and chronic health outcomes? Participants will: * Participate in a community program for youth that will strengthen connection to 'āina (land) and culture. Programs in the summer are 5 hours per day, 4 days a week, for 4 weeks. Programs in the school-year are 2.5 hours per day, 2 days a week, for 16 weeks. * Take surveys on their demographics, general well-being, mental health, and chronic health conditions they may have at 4 different times: Before the program begins, immediately after the program finishes, 3-4 months after finishing, and 6-8 months after finishing. * Have an adult family member complete surveys on their youth's demographics and general well-being at the same 4 times

Recruiting
Has No Placebo

Waianae Coast Comprehensive Health Center

May M Okihrio, MD, MS

Have you considered Rhinocort Allergy clinical trials?

We made a collection of clinical trials featuring Rhinocort Allergy, we think they might fit your search criteria.
Go to Trials
Image of Resilient Roots: Functional Medicine in Charlottesville, United States.

Ketogenic and Carnivore Diets for Inflammatory Bowel Disease and Rheumatoid Arthritis

18 - 64
All Sexes
Charlottesville, VA

This study is a randomized controlled clinical trial evaluating whether two therapeutic dietary approaches - a ketogenic diet and a carnivore (lion) diet - can improve quality of life, reduce symptoms, and influence measures of disease activity in adults with inflammatory bowel disease \[ulcerative colitis and Crohn's disease\] (IBD) or rheumatoid arthritis (RA). Participants will be randomized into one of three groups: 1) Ketogenic Diet, 2) Carnivore (Lion) Diet or 3) Wait-List Control. Participants randomized to a dietary group (ketogenic diet or carnivore diet) will be provided guidance on their specific dietary therapy and answer questions about their symptoms and quality of life at different intervals over a 24 week period. Participants will also complete laboratory testing at different intervals to assess for changes in nutritional status, cardiometabolic health and markers of immune activation and inflammation. Participants initially placed on the wait-list group will be asked similar questions about their symptoms and quality of life and complete the same laboratory testing as participants in a dietary group. Participants on the wait list will then be compared to participants following a specific dietary pattern to assess for any differences between the 2 groups. After 12 weeks, participants on the wait list will be randomized to a dietary group (ketogenic diet or carnivore diet) and followed in a similar fashion for an additional 12 week period.

Recruiting
Has No Placebo

Resilient Roots: Functional Medicine

Robert D Abbott, MD

Image of UCSF Medical Center in San Francisco, United States.

Upadacitinib for Ulcerative Colitis

18 - 75
All Sexes
San Francisco, CA

The goal of this clinical trial is to learn if the oral medication upadacitinib can safely and effectively treat acute severe ulcerative colitis (ASUC) in adults who are hospitalized. It will also evaluate whether upadacitinib can be used without corticosteroids during initial treatment. The main questions it aims to answer are: 1. Does upadacitinib reduce treatment failure by Day 14 (defined as need for colectomy or rescue therapy)? 2. What side effects and safety events occur when using upadacitinib in hospitalized patients with ASUC? Researchers will compare outcomes in participants receiving upadacitinib to a historical group of similar patients previously treated with standard therapies, including intravenous corticosteroids and infliximab, to determine if upadacitinib improves outcomes. Participants will: 1. Take oral upadacitinib once daily during hospitalization. 2. Undergo routine clinical monitoring, including blood tests and symptom assessments. 3. Be followed after discharge with clinic visits or phone calls for up to 12 months to assess outcomes such as need for additional treatment, surgery, and safety events

Phase 4
Waitlist Available

UCSF Medical Center

Sara Lewin, MD

AbbVie

Have you considered Rhinocort Allergy clinical trials?

We made a collection of clinical trials featuring Rhinocort Allergy, we think they might fit your search criteria.
Go to Trials

Have you considered Rhinocort Allergy clinical trials?

We made a collection of clinical trials featuring Rhinocort Allergy, we think they might fit your search criteria.
Go to Trials